5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and...

5.23 Phase 2 Study of Navitoclax (ABT-263) Safety and Efficacy in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Interim Results

John F. Seymour, Andrew W. Roberts, Dennis A. Carney, Martin J.S. Dyer, Thomas J. Kipps, Michael Hallek, R. Gregory Bociek, Jennifer R. Brown, William G. Wierda, Kanti Rai, Moacyr Ribeiro de Oliveira,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Year:
2011
Language:
english
DOI:
10.1016/j.clml.2011.09.177
File:
PDF, 71 KB
english, 2011
Conversion to is in progress
Conversion to is failed